Latest topics page 32
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 32 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Conference abstracts as evidence: the weakest common citation
On the subject in the title: Conference abstracts as evidence: the weakest common citation Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+1 | 5 | 2k | 9mo |
|
Sleep tracking data and its considerable limitations
Sleep tracking data and its considerable limitations — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+109 | 126 | 61k | 9mo |
|
Lateral-flow and colorimetric approaches: the specificity problem
Lateral-flow and colorimetric approaches: the specificity problem — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
2 | 4k | 9mo | |
|
Airline travel with a temperature-sensitive injectable — what changed since
Airline travel with a temperature-sensitive injectable — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
|
+89 | 95 | 5.3k | 9mo |
|
How the published trials escalated, tabulated side by side — does this still hold?
Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? A question about technique rather than about dose. I have been…
|
2 | 8.9k | 9mo | |
|
Follow-up: What a seizure notice actually says
What a seizure notice actually says — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
|
+35 | 41 | 490 | 9mo |
|
New subcategory: rationale and scope
On the subject in the title: New subcategory: rationale and scope Working notes rather than a conclusion. Process question about how this site works. I have read the guidelines and the trust-level page and I…
|
+126 | 138 | 13k | 9mo |
|
Semaglutide versus liraglutide head to head: reading STEP 8 carefully
On the subject in the title: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019) cited in support of a…
|
+72 | 81 | 1.5k | 9mo |
|
The most useful thing you learned here that was not the answer you came for — a second dataset
Posting this under the heading it deserves: The most useful thing you learned here that was not the answer you came for — a second dataset Everything below is what sits behind that. Lower-stakes topic, but…
|
+111 | 121 | 6.6k | 9mo |
|
Injecting into an area that has become firm: why not to — does this still hold?
Asking directly, because I could not find a straight answer: Injecting into an area that has become firm: why not to — does this still hold? I have read the maintained page on this and I still have a gap, so…
|
2 | 49k | 9mo | |
|
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on
Posting this under the heading it deserves: SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med…
|
+122 | 136 | 48k | 9mo |
|
Power cut for eleven hours: how I assessed it afterwards
Posting this under the heading it deserves: Power cut for eleven hours: how I assessed it afterwards Everything below is what sits behind that. Practical question with the units stated, because I have seen…
|
+102 | 109 | 1.4k | 9mo |
|
Pinch or no pinch, and how needle length changes the answer
Pinch or no pinch, and how needle length changes the answer Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a gap,…
|
+118 | 126 | 11k | 9mo |
|
What happens after your first post: likes, trust levels, and why none of it matters much — what changed since
The question in the title: What happens after your first post: likes, trust levels, and why none of it matters much — what changed since I will give what I have already checked below so nobody repeats it. I…
|
+105 | 118 | 57k | 9mo |
|
Payment mechanics and the recovery options that do not exist
Payment mechanics and the recovery options that do not exist Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal,…
|
+80 | 89 | 24k | 9mo |
|
Injection discomfort: needle gauge, volume, temperature, technique — one year on
Posting this under the heading it deserves: Injection discomfort: needle gauge, volume, temperature, technique — one year on Everything below is what sits behind that. Practical question with the units…
|
2 | 102 | 9mo | |
|
Revisiting: Power cut for eleven hours: how I assessed it afterwards
Revisiting: Power cut for eleven hours: how I assessed it afterwards — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing…
|
4 | 195 | 9mo | |
|
Coming back to: Resolution and tailing factor: real acceptance criteria
Posting this under the heading it deserves: Resolution and tailing factor: real acceptance criteria Everything below is what sits behind that. Posting the method first, because I know what the first three…
|
+93 | 112 | 5.7k | 9mo |
|
What a 2 ppm match establishes, and what it does not
What a 2 ppm match establishes, and what it does not — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity arithmetic and I would like it…
|
+56 | 60 | 5.2k | 9mo |
|
A preprint whose numbers changed substantially at publication
A preprint whose numbers changed substantially at publication — setting out what I have, and where I think it stops being reliable. Session topic: SURMOUNT-2 ( Lancet , 2023). Please read it before posting;…
|
+90 | 95 | 21k | 9mo |
|
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept Reporting something rather than asking about it, in case the pattern…
|
+7 | 11 | 26k | 9mo |
|
A checklist for reading a certificate in under two minutes — does this still hold?
A checklist for reading a certificate in under two minutes — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this…
|
+49 | 55 | 15k | 9mo |
|
Theoretical plates: useful number or ritual?
Theoretical plates: useful number or ritual? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I repeat it…
|
2 | 284 | 9mo | |
|
Coming back to: A community side-effect dataset, with its response rate and biases
On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Posting the method first, because I know what the first three replies…
|
+27 | 31 | 46k | 9mo |
|
Realistic expectations for strength while losing weight quickly — does this still hold?
Realistic expectations for strength while losing weight quickly — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Maintenance rather than loss,…
|
2 | 11k | 10mo | |
|
What the GIP component of tirzepatide is thought to contribute, and how confident we can be — the long version
Asking directly, because I could not find a straight answer: What the GIP component of tirzepatide is thought to contribute, and how confident we can be — the long version Comparing PIONEER 6 ( N Engl J Med ,…
|
+48 | 52 | 609 | 10mo |
|
Follow-up: Subcutaneous absorption kinetics and site differences
Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere. A…
|
4 | 9.9k | 10mo | |
|
An orphaned page with no inbound links — the long version
Posting this under the heading it deserves: An orphaned page with no inbound links — the long version Everything below is what sits behind that. Process question about how this site works. I have read the…
|
+14 | 18 | 21k | 10mo |
|
Follow-up: Why the titration planner refuses to produce a schedule below a floor
The question in the title: Why the titration planner refuses to produce a schedule below a floor I will give what I have already checked below so nobody repeats it. I would like to understand what this number…
|
+120 | 146 | 14k | 10mo |
|
Which panel is worth repeating and which is worth ignoring
The question in the title: Which panel is worth repeating and which is worth ignoring I will give what I have already checked below so nobody repeats it. General question, not a request for advice about my…
|
+125 | 133 | 17k | 10mo |